|
CDNA
|
CareDx, Inc.
|
US
|
NASDAQ
|
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|
|
MDXG
|
MiMedx Group, Inc
|
US
|
NASDAQ
|
|
MIRO
|
Miromatrix Medical Inc.
|
US
|
NASDAQ
|
|
NUVA
|
NuVasive, Inc.
|
US
|
NASDAQ
|
|
PLUR
|
Pluri Inc.
|
US
|
NASDAQ
|
|
TALS
|
Talaris Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TMDX
|
TransMedics Group, Inc.
|
US
|
NASDAQ
|
|
XTNT
|
Xtant Medical Holdings, Inc.
|
US
|
AMEX
|
|
ZIMV
|
ZimVie Inc.
|
US
|
NASDAQ
|
|
BBIXF
|
Bonus Biogroup Ltd
|
US
|
OTC
|
|
ENDV
|
Endonovo Therapeutics Inc
|
US
|
OTC
|
|
MEOBF
|
Mesoblast Ltd
|
US
|
OTC
|
|
VRCDF
|
Verici Dx Plc
|
US
|
OTC
|
|
XVIPF
|
Xvivo Perfusion AB (publ)
|
US
|
OTC
|
|
BIOS
|
BioSenic S.A.
|
BE
|
BR
|
|
1K9
|
Caredx Inc
|
DE
|
F
|
|
049180
|
Cellumed Co. Ltd
|
KR
|
KQ
|
|
MAAT
|
Maat Pharma SA
|
FR
|
PA
|
|
IDOGEN
|
Idogen AB
|
SE
|
ST
|